Effects of Exercise in Patients with Lipedema
Launched by ILKE KESER · Feb 2, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of exercise on women with a condition called lipedema, which causes swelling in the legs and sometimes the arms. The goal is to see how exercise can help reduce swelling, pain, and improve strength and physical ability. Women aged 65 to 74 who have been diagnosed with lipedema (stages 1, 2, or 3) may be eligible to participate. However, those with certain medical conditions that limit their ability to exercise or who have had recent surgeries may not qualify.
Participants in the trial can expect to take part in a structured exercise program over six weeks, which includes warm-ups, strength training, and cool-downs, all designed to be manageable based on their individual comfort levels. They will undergo various assessments before and after the program to measure changes in swelling, pain, and muscle strength. Those in the control group will receive advice on managing lipedema and physical activity but will not participate in the exercise program. This study aims to provide valuable insights into how exercise can support women with lipedema in their daily lives.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Having a diagnosis of Lipedema,
- • Patients with Lipedema stage 1,2 and 3
- Exclusion Criteria:
- • Individuals with cardiopulmonary, rheumatic or neurological diagnoses that have symptoms severe enough to prevent participation in exercise,
- • History of cancer, surgery or trauma that may affect the circulatory system,
- • History of liposuction or orthopedic surgery within the last year,
- • Individuals who cannot mobilize independently.
About Ilke Keser
Ilke Keser is a dedicated clinical trial sponsor committed to advancing medical research through innovative and ethical study designs. With a focus on improving patient outcomes, ilke Keser collaborates with healthcare professionals, regulatory bodies, and research institutions to facilitate the development of new therapies and interventions. The organization emphasizes rigorous adherence to regulatory standards and best practices, ensuring the integrity and reliability of trial results. By fostering a culture of collaboration and transparency, ilke Keser strives to contribute significantly to the scientific community and enhance the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Emek, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported